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SUMMARY. This study introduced a novel phase separation technique for the microencapsulation of
metoprolol tartrate as a model. Non-solvent addition coacervation technique was employed for the loading
of drug into ethylcellulose, a hydrophobic plastic polymer. Dichloromethane (DCM) and paraffin oil were
employed as solvent and non-solvent, respectively. Microparticle batches abbreviated as M1, M2 and M3
were formulated by embedding 1 g of drug into 1 g, 2 g and 3 g of polymer, respectively followed by direct
compression into tabletted microparticulate batches named a T1, T2 and T3, respectively. The drug and
polymer remained intact in encapsulated form as confirmed by FTIR, XRD and DSC. However, a slight
change in drug nature from crystalline to amorphous behavior and an endothermic peak for metoprolol
tartrate at 130 ºC was observed in drug and microparticle thermograms. Slightly aggregated spherical
free flowing microparticles in a size range of 64 μm-103 μm were obtained. The entrapment efficiency
ranged from 77% to 89%. The straight line obtained from a plot between square root of time (Hrs) versus
drug release (%) and regression co-efficient (R2) confirmed that best fit model to all dissolution profiles
was Higuchi’s model. The modes of drug release from microparticles and tabletted microparticles were
Quasi-Fickian diffusion and anomalous diffusion, respectively. T3 was selected as an optimum formula-
tion as its dissolution profile resembled (f2 = 76.25) Mepressor® (Novartis Pharma-Pakistan). The acceler-
ated stability study, regarding dissolution behavior and drug contents, at 40ºC/75% RH proved T3 stable
in 40 ºC/75% RH for six months. Non-solvent addition coacervation technique involving comparatively
safe solvents such as dichloromethane and paraffin oil as solvent and non-solvent, respectively is a good
techniques for the encapsulation of Biopharmaceutics Classification System class I drugs such as metopro-
lol tartrate.
